1. Nutex Health Inc. faces a class action lawsuit for alleged securities fraud. 2. The lawsuit encompasses statements made from August 2024 to August 2025. 3. Allegations include false financial disclosures and issues with internal controls. 4. Investors have until October 21, 2025, to participate in the lawsuit. 5. No fees are required to join the lawsuit for affected investors.
Class action lawsuits typically lead to a significant decline in investor confidence, showcased historically in companies like Enron and Lehman Brothers. Concerns over alleged fraud and financial misreporting could severely dampen NUTX's stock value.
The lawsuit directly implicates NUTX's financial health and legal standing, which are crucial for investor sentiment and stock performance. Ongoing litigation can heavily impact how investors view the risk associated with holding NUTX stocks.
The negative ramifications from this lawsuit are immediate, likely affecting stock prices quickly as news disseminates through the market. In similar cases, stocks react rapidly to legal troubles, often dropping sharply as uncertainty rises.
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ:NUTX) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/nutex-health-inc-lawsuit-submission-form?prid=165270&wire=4
NUTX investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) HaloMD, a third-party IDR vendor, was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (iii) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material weaknesses in its internal controls over financial reporting; (iv) as a result, the Company was unable to effectively account for the treatment of certain of its stock based compensation obligations; (v) as a result, Nutex improperly calculated these stock based compensation obligations as equity rather than liabilities; (vi) the foregoing increased the risk that the Company would be unable to timely file certain financial reports with the SEC; (vii) accordingly, Nutex's business and/or financial prospects were overstated; and (viii) as a result, defendants' public statements were materially false and misleading at all relevant times.
WHAT'S NEXT? If you suffered a loss in Nutex Health Inc. during the relevant time frame, you have until October 21, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/class-action-filed-against-nutex-health-inc-nutx---october-21-2025-deadline-to-join--contact-levi--korsinsky-302547255.html
SOURCE Levi & Korsinsky, LLP